BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29939946)

  • 41. Insertion/deletion gene polymorphism of the angiotensin-converting enzyme and blood pressure changes in older adults. The Rotterdam study.
    Mattace-Raso FU; Sie MP; van der Cammen TJ; Safar ME; Hofman A; van Duijn CM; Witteman JC
    J Hum Hypertens; 2007 Sep; 21(9):736-40. PubMed ID: 17495950
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [ANALYSIS OF THE ASSOCIATIONS BETWEEN ANGIOTENSIN-CONVERTING ENZYME GENE POLYMORPHISM AND ARTERIAL HYPOTENSION IN PREMATURE INFANTS WITH EARLY ONSET BACTERIAL INFECTIONS].
    Kovaleva E; Pokhylko V; Chernyavskaya Y; Kalyuzka E; Poltoropavlov V
    Georgian Med News; 2015 Nov; (248):60-8. PubMed ID: 26656553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Angiotensin converting enzyme gene insertion/deletion polymorphism, angiotensinogen gene polymorphisms, family history of hypertension, and childhood blood pressure.
    Taittonen L; Uhari M; Kontula K; Kainulainen K; Miettinen H; Turtinen J; Nuutinen M
    Am J Hypertens; 1999 Sep; 12(9 Pt 1):858-66. PubMed ID: 10509542
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Cardiometabolic Risk Factors: A Study Among Bhil Tribal Population from Two Environmental Settings.
    Mishra D; Naorem K; Saraswathy KN
    Biochem Genet; 2018 Aug; 56(4):295-314. PubMed ID: 29435690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. I/D polymorphism of the angiotensin-converting enzyme gene does not predict isolated systolic or systolic-diastolic hypertension in the elderly.
    Johnson AG; Simons LA; Friedlander Y; Simons J; Davis DR; MaCallum J
    J Hum Hypertens; 1996 Mar; 10(3):167-9. PubMed ID: 8733034
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Polymorphism of genes of the renin-angiotensin system ACE, AT1R, and AT2R in patients with pulmonary tuberculosis].
    Ogarkov OB; Sin'kov VV; Medvedeva TV; Gutnikova MIu; Nekipelov OM; Raevskaia LIu; Kuptsevich NIu; Kostiunin KIu; Skvortsova RG
    Mol Gen Mikrobiol Virusol; 2008; (2):12-8. PubMed ID: 18488444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impacts of ACE insertion/deletion variant on cardiometabolic risk factors, premature coronary artery disease, and severity of coronary lesions.
    Luo Z
    Sci Rep; 2024 Jun; 14(1):13171. PubMed ID: 38849492
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The link between angiotensin-converting enzyme genotype and pulmonary artery pressure in patients with COPD.
    Tkácová R; Joppa P; Stancák B; Salagovic J; Misíková S; Kalina I
    Wien Klin Wochenschr; 2005 Mar; 117(5-6):210-4. PubMed ID: 15875760
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mortality in patients with hypertension on angiotensin-I converting enzyme (ACE)-inhibitor treatment is influenced by the ACE insertion/deletion polymorphism.
    Bleumink GS; Schut AF; Sturkenboom MC; van Duijn CM; Deckers JW; Hofman A; Kingma JH; Witteman JC; Stricker BH
    Pharmacogenet Genomics; 2005 Feb; 15(2):75-81. PubMed ID: 15861031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of ACE gene insertion/deletion polymorphism with birth weight, blood pressure levels, and ACE activity in healthy children.
    Ajala AR; Almeida SS; Rangel M; Palomino Z; Strufaldi MW; Puccini RF; Araujo RC; Casarini DE; Franco MC
    Am J Hypertens; 2012 Jul; 25(7):827-32. PubMed ID: 22647781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacogenetic association of the angiotensin-converting enzyme insertion/deletion polymorphism on blood pressure and cardiovascular risk in relation to antihypertensive treatment: the Genetics of Hypertension-Associated Treatment (GenHAT) study.
    Arnett DK; Davis BR; Ford CE; Boerwinkle E; Leiendecker-Foster C; Miller MB; Black H; Eckfeldt JH
    Circulation; 2005 Jun; 111(25):3374-83. PubMed ID: 15967849
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of the I/D polymorphism of the angiotensin-converting enzyme gene on the outcome of microalbuminuria in essential hypertension.
    Redon J; Chaves FJ; Liao Y; Pascual JM; Rovira E; Armengod ME; Cooper RS
    Hypertension; 2000 Jan; 35(1 Pt 2):490-5. PubMed ID: 10642347
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction.
    Samani NJ; O'Toole L; Martin D; Rai H; Fletcher S; Lodwick D; Thompson JR; Morice AH; Channer K; Woods KL
    J Am Coll Cardiol; 1996 Aug; 28(2):338-44. PubMed ID: 8800107
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sex-dependent association between angiotensin-converting enzyme insertion/deletion polymorphism and obesity in relation to sodium intake in children.
    Yang SJ; Kim S; Park H; Kim SM; Choi KM; Lim Y; Lee M
    Nutrition; 2013 Mar; 29(3):525-30. PubMed ID: 23398920
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasma Kallikrein and Angiotensin I-converting enzyme N- and C-terminal domain activities are modulated by the insertion/deletion polymorphism.
    Almeida SS; Barros CC; Moraes MR; Russo FJ; Haro AS; Rosa TS; Alves MF; Pesquero JB; Carmona AK; Bacurau RF; Araújo RC
    Neuropeptides; 2010 Apr; 44(2):139-43. PubMed ID: 20064660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Angiotensin-converting enyme insertion/deletion polymorphism and blood pressure regulation in type 2 diabetic patients].
    Krajina-Andricević M; Zibar L; Glavas-Obrovac- L; Stefanić M; Avdicević M; Barbić J
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():14-9. PubMed ID: 23120809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association between angiotensin-converting enzyme gene polymorphisms and regression of left ventricular hypertrophy in patients treated with angiotensin-converting enzyme inhibitors.
    Kohno M; Yokokawa K; Minami M; Kano H; Yasunari K; Hanehira T; Yoshikawa J
    Am J Med; 1999 May; 106(5):544-9. PubMed ID: 10335726
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the insertion/deletion polymorphism of the angiotensin-converting enzyme gene on response to angiotensin-converting enzyme inhibitors in patients with heart failure.
    O'Toole L; Stewart M; Padfield P; Channer K
    J Cardiovasc Pharmacol; 1998 Dec; 32(6):988-94. PubMed ID: 9869506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Contribution of angiotensin I converting enzyme gene polymorphism and angiotensinogen gene polymorphism to blood pressure regulation in essential hypertension.
    Mondorf UF; Russ A; Wiesemann A; Herrero M; Oremek G; Lenz T
    Am J Hypertens; 1998 Feb; 11(2):174-83. PubMed ID: 9524045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Angiotensin-converting enzyme I/D polymorphism and hypertension: the Ohasama study.
    Matsubara M; Suzuki M; Fujiwara T; Kikuya M; Metoki H; Michimata M; Araki T; Kazama I; Satoh T; Hashimoto J; Hozawa A; Ohkubo T; Tsuji I; Katsuya T; Higaki J; Ogihara T; Satoh H; Imai Y
    J Hypertens; 2002 Jun; 20(6):1121-6. PubMed ID: 12023681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.